Our Mastery
Testimonial
- "Amazing success ratio in such uncertain market and paid service is very affordable ...Good job done by your team...keep it up guys."
-Venkat (Chennai)
Party Plot Owner - "I am trading in stock market since last 8 years; I have subscribed services from many advisory companies. Conclusion is that no one can provide 100% accuracy in this NSE market. But accuracy of intraday tips from this firm is the highest among all share tips companies" Rahul Varma (Mumbai)
Owner of an Insurance Firm - "I have taken free trial of intraday tips for 2 days and 80% call is profitable. Then I have subscribed paid membership for trading advice and now I am quite satisfied with services. Important thing is do not think more; Just trade what you are suggested" -Kevin Patel (Ahmedabad)
BDM at IT Company - "Made Good Profit in the Intraday, Jackpot Calls, F&o Tips. Overall Service is very good. Especially I like your Fast tips Sms Service & Exit Call System. Your tips have very good performance." -Manoj Arora (Delhi)
CEO of Real Estate Company
Sun Pharma Advanced Research Company Ltd share price today (on 1 October 2023).
We Provide Best stock tips for Sun Pharma Advanced Research Company Ltd. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of Sun Pharma Advanced Research Company Ltd with today performance in nse market. Contact Us for Jackpot Stock tips.
Get Free Stock Tips for Sun Pharma Advanced Research Company Ltd
Live Chart - Sun Pharma
BSE: 532872 | NSE: SPARC | ISIN: INE232I01014 Market Cap: [Rs.Cr.] 2,014 | Face Value: [Rs.] 1 Industry: MiscellaneousSun Pharmaceutical Advanced Research Company Ltd is an international research based pharmaceutical company engaged in creating new drugs and delivery systems. The company works on innovation and new product development for global markets. They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). The company designs and develops therapies for allergy and inflammation. They also designs and develops pro-drugs (chemical delivery systems) for marketed drugs that have poor oral absorption profile, which include Biodegradable implant or injection, Nanoemulsion, Dry Powder Inhalation Technology, Wrap Matrix Controlled Release Systems and Gastro Retentive System for Controlled Release. The company's SUN 1334 H is a novel antiallergic molecule, which is in phase II clinical trials in the United States.
This is a selective histamine H1 receptor antagonist used for the therapy of allergic disorders such as seasonal and perennial allergic rhinitis, and urticaria. The company's SUN-S 461 is an anti-inflammatory molecule for use in the treatment of asthma/ allergic rhinitis. SUN-44, a prodrug of gabapentin, is being developed as a gabapentin with improved pharmacokinetics. Sun Pharmaceutical Advanced Research Company Ltd was incorporated on March 1, 2006 as an innovative and development company. They commenced their operations on March 22, 2006. As per the scheme of arrangement, all the assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking stands transferred and vested in the company with effect from the appointed date on February 28, 2007. The de-merger became effective on March 28, 2007.
On the scheme being effective, the company ceased to be the subsidiary of Sun Pharmaceutical Industries Ltd, the de-merged company. Pursuant to the scheme, the company issued and allotted 19,44,18,898 equity shares of Re 1 each to the equity shareholders of Sun Pharmaceutical Industries Ltd as on the record date, April 30, 2007. The equity shares of the company were listed on the Bombay Stock Exchange Ltd (BSE), and the National Stock Exchange of India Ltd with effect from 18 July, 2007. During the year 2009-10, the Department of Scientific and Industrial Research (DSIR), Government of India sanctioned a 15 year unsecured soft loan under their Drug and Pharmaceutical Research Programme for a project of the company.
Under one plan with Unbelievable lowest price
( Equity cash, Nse f&otips, jackpot tips, sure shot call, btst/stbt call/nifty tips/bank nifty tips)
free trial available for 2 days
Daily Intraday free Nifty Level with 90% Accuracy
to Earn daily Rupees 10000 to 15000
Our all call under in one plan
(equity, fno, jackpot, bank nifty tips )
Nse Listed Companies with Live Charts
with live charts starting with that Alphabet.)
| A | B | C | D | E | F | G | H | I | J |
| K | L | M | N | O | P | Q | R | S | T |
| U | V | W | X | Y | Z |
